This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Long-term follow-up of OPGs in neurofibromatosis type 1

Long-term follow-up of OPGs in neurofibromatosis type 1
Reviewed by Tasmin Berman

7 April 2021 | Tasmin Berman | EYE - Neuro-ophthalmology
Share This

This retrospective observational case series reports outcomes of children followed-up for at least 10 years with optic pathway glioma (OPGs) related to neurofibromatosis type 1 (NF1) between January 1985 and July 2007. They observed 45 children for a mean of 14 years (range 10-21 years) recording their visual acuity per eye and per patient and the presence of optic nerve head pallor. They found that abnormal visual acuity (considered moderate to severe impairment) in the more severely affected eye was present in 36% of the patients and in both eyes in 11%. Optic nerve head pallor of one or both nerves was present in 62%. Nearly all patients who were asymptomatic at presentation with normal visual acuity and optic nerves, preserved their good vision in both eyes. They therefore concluded that children with NF1-associated OPG whose examination signs and symptoms were normal at initial examination had excellent long-term visual and anatomical outcomes. This is the first study with very long follow-up of OPG in NF1. However by excluding all those patients who had less than 10 years follow-up means that those patients who may have no visual implications and therefore less follow-up have not been included.

Neurofibromatosis type 1-associated optic pathway glioma in children: a follow-up of 10 years or more.
Kinori M, Armarnik S, Listernick R, et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY
2020;221:91-6.
Share This
CONTRIBUTOR
Tasmin Berman

University of Liverpool, Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency